Paper Details

  1. Home
  2. Paper Details

Tolerability of Erythrocyte Ribavirin Triphosphate Concentrations Depends on the ITPA Genotype.

Author: InoueAkiko, KomiyamaTakako, MatsumuraHaruka, MizunumaTomohiko, OtoriKatsuya, TanakaYoichi, YokomoriHiroaki

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study evaluated the time-dependent association of ribavirin triphosphate concentrations in erythrocytes, ribavirin-induced toxicity, and virological response to ribavirin treatment for hepatitis C.
Paper Details　
Original Abstract of the Article :
Ribavirin (RBV) is an antiviral drug that is part of the current standard therapy for chronic hepatitis C (CHC). It is enzymatically converted to ribavirin triphosphate (RTP) that inhibits the activity of viral RNA polymerase, thereby preventing viral replication. However, one of its adverse effects...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1097/FTD.0000000000000626

データ提供：米国国立医学図書館（NLM）

ITPA Genotype and Ribavirin Tolerability in Hepatitis C Treatment

This research delves into the world of antiviral therapy, focusing on the role of ITPA genotype in determining the tolerability of ribavirin, a crucial drug used to treat chronic hepatitis C (CHC). The study explores the relationship between erythrocyte ribavirin triphosphate (RTP) concentrations, ITPA genotype, and the occurrence of adverse effects, providing valuable insights into personalized medicine and optimizing treatment strategies. It's like navigating a complex desert of genetic variations and drug metabolism, seeking to tailor treatment to individual patient needs.

ITPA Genotype Influences Ribavirin Tolerability

The research reveals that the ITPA genotype significantly influences ribavirin tolerability, highlighting the importance of genetic testing for optimizing treatment strategies. Individuals with certain ITPA variants may be more prone to ribavirin-induced anemia, emphasizing the need for careful monitoring and potentially adjusted dosages. It's like finding a hidden map of genetic variations that can guide us through the desert of drug metabolism, ensuring a safe and effective journey for each patient.

Personalized Medicine for Hepatitis C Treatment

The study's findings underscore the importance of personalized medicine in managing hepatitis C. By considering individual ITPA genotype and RTP levels, healthcare providers can tailor treatment plans to minimize adverse effects and optimize treatment outcomes. It's like finding a personalized oasis of effective therapy in a vast desert of hepatitis C treatment options, ensuring a safe and successful journey for each patient.

Dr.Camel's Conclusion

This research highlights the importance of personalized medicine in managing hepatitis C, emphasizing the role of ITPA genotype in ribavirin tolerability. It's a reminder that in the vast desert of drug therapy, understanding individual genetic variations can lead to better patient care and outcomes.

Date :
  1. Date Completed 2020-03-10
  2. Date Revised 2023-12-13
Further Info :

Pubmed ID

30817703

DOI: Digital Object Identifier

10.1097/FTD.0000000000000626

Related Literature

Article Analysis
・Effects of simeprevir
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.